News

The AI video-generation startup has launched a $10 million venture fund to invest in early-stage companies building across AI, media, and world simulation, the company’s founders told TechCrunch.

Allbirds, the wool sneaker brand that became a kind of unofficial uniform for the Silicon Valley set, has agreed to sell all of its assets and intellectual property to American Exchange Group for $39 million

SpaceX, the technology conglomerate founded by Elon Musk, reportedly filed disclosures confidentially with the U.S. Securities and Exchange Commission ahead of an initial public offering.

Telecoms giant MTN Group retained its position as the country’s most valuable brand for a 13th consecutive year, with a valuation of roughly $2.7 billion.

Uber is buying Berlin-based startup Blacklane, which provides on-demand, black-car chauffeur services, as the ride-hail giant expands deeper into luxury and executive travel services.

Egypt and Cyprus have signed a framework agreement to expand cooperation in natural gas, as both countries move to strengthen the Eastern Mediterranean’s role in global energy supply.

Hungarian Government Scholarship (Stipendium Hungaricum)Discipline: All disciplines Level: Bachelor's, Master's, PhD Sponsor: Hungarian Government

African Liberty, a platform that promotes civil discussions on the continent, has announced the opening of applications for its 2026–2027 writing fellowship.

AfriWallStreet is not just another platform—it is positioning itself as the definitive home of professionals and businesses across Africa and its global diaspora.

Employee health benefits platform Plum Insurance has raised Rs 193 crore ($20.5 million) in its Series B round led by Peak XV Partners. Existing investor Tanglin Venture Partners increased its stake,

Deccan AI, a startup supplying post-training data and evaluation work, has raised $25 million in a Series A round led by A91 Partners, with participation from Susquehanna International Group (SIG) and Prosus Ventures.

Generative-AI drug developer Insilico Medicine said on Sunday that it has agreed a global licensing and research deal with US drugmaker Eli Lilly, that could be worth up to US$2.75 billion